BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2459056)

  • 1. Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm.
    Aldrich CJ; Rodgers JR; Rich RR
    Immunogenetics; 1988; 28(5):334-44. PubMed ID: 2459056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative ability of Qdm/Qa-1b, kb, and Db to protect class Ilow cells from NK-mediated lysis in vivo.
    Jia SH; Kurepa Z; Bai A; Forman J
    J Immunol; 2000 Dec; 165(11):6142-7. PubMed ID: 11086047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.
    Aldrich CJ; Waltrip R; Hermel E; Attaya M; Lindahl KF; Monaco JJ; Forman J
    J Immunol; 1992 Dec; 149(12):3773-7. PubMed ID: 1460275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide.
    Cotterill LA; Stauss HJ; Millrain MM; Pappin DJ; Rahman D; Canas B; Chandler P; Stackpoole A; Simpson E; Robinson PJ; Dyson PJ
    Eur J Immunol; 1997 Sep; 27(9):2123-32. PubMed ID: 9341749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.
    Li L; Sullivan BA; Aldrich CJ; Soloski MJ; Forman J; Grandea AG; Jensen PE; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3707-15. PubMed ID: 15356116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens.
    Stroynowski I; Forman J; Goodenow RS; Schiffer SG; McMillan M; Sharrow SO; Sachs DH; Hood L
    J Exp Med; 1985 May; 161(5):935-52. PubMed ID: 2580938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Qa-1 alloantigens. II. Evidence for the expression of two Qa-1 molecules by the Qa-1d genotype and for cross-reactivity between Qa-1 and H-2K.
    Cook RG; Jenkins RN; Flaherty L; Rich RR
    J Immunol; 1983 Mar; 130(3):1293-9. PubMed ID: 6822734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Qa2 subregion controls the expression of two antigens recognized by H-2-unrestricted cytotoxic T cells.
    Forman J; Trial J; Tonkonogy S; Flaherty L
    J Exp Med; 1982 Mar; 155(3):749-67. PubMed ID: 6174664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells.
    Chun T; Aldrich CJ; Baldeón ME; Kawczynski LV; Soloski MJ; Gaskins HR
    Immunology; 1998 May; 94(1):64-71. PubMed ID: 9708188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.
    Chen L; Reyes-Vargas E; Dai H; Escobar H; Rudd B; Fairbanks J; Ho A; Cusick MF; Kumánovics A; Delgado J; He X; Jensen PE
    J Immunol; 2014 Aug; 193(3):1427-39. PubMed ID: 24958902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen.
    Aldrich CJ; DeCloux A; Woods AS; Cotter RJ; Soloski MJ; Forman J
    Cell; 1994 Nov; 79(4):649-58. PubMed ID: 7525079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of a new Qa antigenic specificity, "Qa-m9," whose expression is under complex genetic control.
    Sutton VR; Hogarth PM; McKenzie IF
    J Immunol; 1983 Sep; 131(3):1363-7. PubMed ID: 6193187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of determinants encoded by four Qa-1 genotypes and their recognition by cloned cytotoxic T lymphocytes.
    Jenkins RN; Rich RR
    J Immunol; 1983 Nov; 131(5):2147-53. PubMed ID: 6195252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Domain TCR-like Antibody Selective for the Qa-1
    Ghaffari S; Upchurch-Ange K; Gimlin S; Tripathi T; Sluijter M; Middelburg J; van Hall T; Weidanz J
    J Immunol; 2022 May; 208(9):2246-2255. PubMed ID: 35418467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qa-1-associated antigens. IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition.
    Nell LJ; Cook RG; Rich RR
    Transplantation; 1982 Jul; 34(1):54-9. PubMed ID: 6181592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of the anti-Qa-1 cytotoxic T lymphocyte repertoire: definition of the Qa-1d and Qa-1c alloantigens and cross-reactivity with H-2.
    Aldrich CJ; Jenkins RN; Rich RR
    J Immunol; 1986 Jan; 136(2):383-8. PubMed ID: 2416805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of primary cytotoxic T lymphocyte responses generated during mixed leukocyte culture with H-2d identical Qa-1-disparate cells.
    Huston DP; Tavana G; Rich RR; Gressens SE
    J Immunol; 1986 Sep; 137(6):1776-81. PubMed ID: 2943800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b.
    DeCloux A; Woods AS; Cotter RJ; Soloski MJ; Forman J
    J Immunol; 1997 Mar; 158(5):2183-91. PubMed ID: 9036964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E beta.
    Wolf PR; Cook RG
    J Exp Med; 1995 Feb; 181(2):657-68. PubMed ID: 7836920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.